A Time-Saving Medical Device that Provides Automated Visualisation for interventional radiologists to Save Lives and Reduce Disabilities in Stroke Patient

在英国，中风每年造成26B GB的成本，在美国为1030亿美元。Medical iSight(UK)Limited(MIS)正在解决一个重要的、未得到满足的全球需求，该需求每年可以拯救数万名英国患者的生命和减少残疾，同时产生3600万英镑的项目后5年收入。MIS的核心项目团队包括克里斯托弗·约翰逊博士、菲利普·普拉特博士、罗伯特·梅里菲尔德博士和安娜·沙夫戈奇女士，后者是一名技术项目总监、一名医疗软件工程师、一名医疗技术软件CTO和一名连续创业者。MIS旨在简化机械血栓切除术(MT)，这是一种相对较新的高效治疗大血管闭塞性缺血性中风的方法。MT是一项高技能和挑战性的程序，需要持续4-5个小时。在其长期计划中，NHS将中风确定为临床优先事项，目标是使英国每个合适的中风患者都能获得MT，在全国范围内开发多达30个能够提供MT的中风中心。与许多竞争对手使用的技术不同，该项目旨在提供在扩展现实环境中(Microsoft HoloLens)的自动3D到2D图像配准和导管尖端跟踪，使程序更简单、更短(C30%)，使用已建立的指标来衡量成功与否。

Strokes in the UK incur annual costs of £26B and in the US $103B. Medical iSight (UK) Limited (MiS) is solving a significant, unmet, global need that could save lives and reduce disability for tens of thousands of UK patients each year, while generating a year-5 post- project revenue of £36M. The core project team from MiS includes Dr Christopher Johnson, Dr Philip Pratt, Dr Robert Merrifield and Ms Anna Schaffgotsch, a technology programme director, a medical software engineer, a medtech software CTO and a serial entrepreneur.MiS aims to simplify Mechanical Thrombectomy (MT), a relatively new and highly effective treatment for large vessel occlusive ischaemic Stroke. MT is a highly skilled and challenging procedure with some lasting 4-5 hours.In its Long Term Plan the NHS identified Stroke as a clinical priority and aims to make MT accessible to every suitable Stroke patient throughout the UK, developing up to 30 Stroke centres capable of delivering MT, nationally.Unlike the technology used by many competitors, this project aims to provide automated 3D to 2D image registration and catheter tip tracking within an extended reality environment (Microsoft HoloLens), making the procedure simpler and shorter (c30%), using established metrics to measure success.